Shelley Orwick

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (12)

Alice Mims

Ohio State University

UNITED STATES

View details

James Blachly

Associate Professor of Internal Medicine

Ohio State University

UNITED STATES

View details

Geoffrey Uy

Professor of Medicine

Washington University School of Medicine

UNITED STATES

View details

Bhavana Bhatnagar

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Mitch Phelps

Ohio State University

UNITED STATES

View details

Tara Lin

University of Kansas Medical Center

UNITED STATES

View details

Bradley W. Blaser

UNITED STATES

View details

Dimitrios Papaioannou

Assistant Professor

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health

UNITED STATES

View details

Eric Eisenmann

Ohio State University

UNITED STATES

View details

Sharyn D. Baker

Ohio State University

UNITED STATES

View details

Najla Alotaibi

SAUDI ARABIA

View details

Deedra Nicolet

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shelley Orwick

Research Interests

Explore related searches

Contact this professor

Articles (13)

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies

CD37 in acute myeloid leukemia: a novel surface target for drug delivery

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A

Collaborators (12)

Alice Mims

James Blachly

Geoffrey Uy

Bhavana Bhatnagar

Mitch Phelps

Tara Lin

Bradley W. Blaser

Dimitrios Papaioannou

Eric Eisenmann

Sharyn D. Baker

Najla Alotaibi

Deedra Nicolet

Make your next move.